Jasper Therapeutics, Inc.

NASDAQ:JSPR

22.35 (USD) • At close October 29, 2024
Bedrijfsnaam Jasper Therapeutics, Inc.
Symbool JSPR
Munteenheid USD
Prijs 22.35
Beurswaarde 337,603,455
Dividendpercentage 0%
52-weken bereik 4 - 31.01
Industrie Biotechnology
Sector Healthcare
CEO Mr. Ronald A. Martell
Website https://jaspertherapeutics.com

An error occurred while fetching data.

Over Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic

Vergelijkbare Aandelen

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.72 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

7.57 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

12.25 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

10.74 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)